FDA Holds Public Hearing & Opens Public Docket on Cannabis-Derived Compounds
The U.S. Food and Drug Administration (FDA) recently held a public hearing on cannabis-derived compounds, including cannabinoids, such as cannabidiol (CBD). The hearing was prompted by industry confusion since the passage of the Agriculture Improvement Act of 2018 (AIA; Pub. …
FDA Holds Public Hearing & Opens Public Docket on Cannabis-Derived Compounds Read more »
